This article needs additional citations for verification. (March 2016) |
The Paul G. Allen Frontiers Group is a Seattle-based bioscience research initiative started in 2016 and funded with an initial investment of $100 million.[1] It is a division of the Allen Institute.[2] Its vision is to identify areas in bioscience that are ripe for a major breakthrough, and then fund specific investigators to pursue advances.[3]
In 2021, the Allen Frontiers Group joined the Open Research Funders Group (ORFG).[4]
Allen Distinguished Investigators
The Distinguished Investigator program "awards grants of $1.5 million of three years in support of early-stage research in biology and medicine that would not otherwise be supported by traditional funding sources."[5]
External links
editReferences
edit- ^ Cha, Ariana Eunjung (2021-10-26). "Philanthropist Paul Allen announces $100 million gift to expand 'frontiers of bioscience'". Washington Post. ISSN 0190-8286. Retrieved 2023-11-07.
- ^ Savchuk, Katia. "Billionaire Paul Allen Pledges $100 Million To Fund Cutting-Edge Life Sciences Research". Forbes. Retrieved 2023-11-07.
- ^ "Microsoft pioneer invests big, again, in bioscience". Sciencemag.org. Retrieved March 24, 2016.
- ^ "Allen Frontiers Group Joins ORFG". Open Research Funders Group. 2021-09-29. Retrieved 2023-11-07.
- ^ "Frontiers Group announces 2021 Allen Distinguished Investigators". Philanthropynewsdigest.org.
 | This article about an organization in the United States is a stub. You can help Wikipedia by expanding it. |
 | This article about a biology organization is a stub. You can help Wikipedia by expanding it. |